Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3696639018 | Product containing precisely hepatitis B surface antigen 10 microgram/0.5 milliliter conventional release suspension for injection vial (clinical drug) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
3696640016 | Hepatitis B surface antigen 10 microgram/0.5 mL suspension for injection vial | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely hepatitis B surface antigen 10 microgram/0.5 milliliter conventional release suspension for injection vial (clinical drug) | Has unit of presentation | Vial (unit of presentation) | false | Inferred relationship | Some | ||
Product containing precisely hepatitis B surface antigen 10 microgram/0.5 milliliter conventional release suspension for injection vial (clinical drug) | Has concentration strength denominator value | un | false | Inferred relationship | Some | 1 | |
Product containing precisely hepatitis B surface antigen 10 microgram/0.5 milliliter conventional release suspension for injection vial (clinical drug) | Has presentation strength denominator value | 0,5 | false | Inferred relationship | Some | 1 | |
Product containing precisely hepatitis B surface antigen 10 microgram/0.5 milliliter conventional release suspension for injection vial (clinical drug) | Has concentration strength numerator unit | microgram (qualifier value) | false | Inferred relationship | Some | 1 | |
Product containing precisely hepatitis B surface antigen 10 microgram/0.5 milliliter conventional release suspension for injection vial (clinical drug) | Has presentation strength numerator unit | microgram (qualifier value) | false | Inferred relationship | Some | 1 | |
Product containing precisely hepatitis B surface antigen 10 microgram/0.5 milliliter conventional release suspension for injection vial (clinical drug) | Has concentration strength denominator unit | Milliliter (qualifier value) | false | Inferred relationship | Some | 1 | |
Product containing precisely hepatitis B surface antigen 10 microgram/0.5 milliliter conventional release suspension for injection vial (clinical drug) | Has presentation strength numerator value (attribute) | dix | false | Inferred relationship | Some | 1 | |
Product containing precisely hepatitis B surface antigen 10 microgram/0.5 milliliter conventional release suspension for injection vial (clinical drug) | Has precise active ingredient | Hepatitis B surface antigen | false | Inferred relationship | Some | 1 | |
Product containing precisely hepatitis B surface antigen 10 microgram/0.5 milliliter conventional release suspension for injection vial (clinical drug) | Has basis of strength substance (attribute) | Hepatitis B surface antigen | false | Inferred relationship | Some | 1 | |
Product containing precisely hepatitis B surface antigen 10 microgram/0.5 milliliter conventional release suspension for injection vial (clinical drug) | Has concentration strength numerator value (attribute) | 20 (qualifier value) | false | Inferred relationship | Some | 1 | |
Product containing precisely hepatitis B surface antigen 10 microgram/0.5 milliliter conventional release suspension for injection vial (clinical drug) | Count of base of active ingredient | un | false | Inferred relationship | Some | ||
Product containing precisely hepatitis B surface antigen 10 microgram/0.5 milliliter conventional release suspension for injection vial (clinical drug) | est un(e) (attribut) | Product manufactured as parenteral dose form (product) | false | Inferred relationship | Some | ||
Product containing precisely hepatitis B surface antigen 10 microgram/0.5 milliliter conventional release suspension for injection vial (clinical drug) | a une forme pharmaceutique (attribut) | suspension injectable | false | Inferred relationship | Some | ||
Product containing precisely hepatitis B surface antigen 10 microgram/0.5 milliliter conventional release suspension for injection vial (clinical drug) | Has presentation strength denominator unit (attribute) | Milliliter (qualifier value) | false | Inferred relationship | Some | 1 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Canada English language reference set (foundation metadata concept)
Concept inactivation indicator reference set
POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)